{"entity":{"type":"insider","cik":"0001831216","url":"/insider/0001831216","json_url":"/insider/0001831216.json","name":"Myles David C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":8,"first":"2021-12-14","last":"2026-01-14","span_basis":"filed_date"},"name_variants":[{"name":"Myles David C.","source":"filing","n_filings":8,"first_seen":"2021-12-14","last_seen":"2026-01-14"}],"transactions":[{"id":5996973,"accession":"0001831216-26-000003","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001831216-26-000003","line_url":"/filing/0001831216-26-000003","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831216","owner_name":"Myles David C.","owner_display_name":"Myles David C.","owner_url":"/insider/0001831216","role":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark":"O","role_mark_label":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CH. DISCOV. & NON-CLIN DEV OFF","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":28.8730234,"price_display":"28.87","price_state":"stated","total_value":1443651.17,"total_display":"1,443,651.17","total_whole":"1,443,651","shares_owned_after":542761.0,"shares_owned_after_display":"542,761","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-14","filed_date":"2026-01-14","scope":"insider","n_lines":2},{"id":5996966,"accession":"0001831216-26-000003","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001831216-26-000003","line_url":"/filing/0001831216-26-000003","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831216","owner_name":"Myles David C.","owner_display_name":"Myles David C.","owner_url":"/insider/0001831216","role":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark":"O","role_mark_label":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CH. DISCOV. & NON-CLIN DEV OFF","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":27.60356,"price_display":"27.60","price_state":"stated","total_value":1380178.0,"total_display":"1,380,178.00","total_whole":"1,380,178","shares_owned_after":542961.0,"shares_owned_after_display":"542,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-13","filed_date":"2026-01-14","scope":"insider","n_lines":2},{"id":5996952,"accession":"0001831216-26-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001831216-26-000003","line_url":"/filing/0001831216-26-000003#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831216","owner_name":"Myles David C.","owner_display_name":"Myles David C.","owner_url":"/insider/0001831216","role":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark":"O","role_mark_label":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CH. DISCOV. & NON-CLIN DEV OFF","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":28.34,"price_display":"28.34","price_state":"stated","total_value":283400.0,"total_display":"283,400.00","total_whole":"283,400","shares_owned_after":144846.0,"shares_owned_after_display":"144,846","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":4856016,"accession":"0001831216-25-000004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001831216-25-000004","line_url":"/filing/0001831216-25-000004","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831216","owner_name":"Myles David C.","owner_display_name":"Myles David C.","owner_url":"/insider/0001831216","role":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark":"O","role_mark_label":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CH. DISCOV. & NON-CLIN DEV OFF","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51000.0,"shares_display":"51,000","price_per_share":30.461638039215686,"price_display":"30.46","price_state":"stated","total_value":1553543.54,"total_display":"1,553,543.54","total_whole":"1,553,544","shares_owned_after":557927.0,"shares_owned_after_display":"557,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-19","filed_date":"2025-12-23","scope":"insider","n_lines":3},{"id":2605220,"accession":"0001415889-24-029027","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-029027","line_url":"/filing/0001415889-24-029027","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831216","owner_name":"Myles David C.","owner_display_name":"Myles David C.","owner_url":"/insider/0001831216","role":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark":"O","role_mark_label":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CH. DISCOV. & NON-CLIN DEV OFF","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13614.0,"shares_display":"13,614","price_per_share":8.676086381665932,"price_display":"8.68","price_state":"stated","total_value":118116.24,"total_display":"118,116.24","total_whole":"118,116","shares_owned_after":598633.0,"shares_owned_after_display":"598,633","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-11","filed_date":"2024-12-11","scope":"insider","n_lines":2},{"id":2605207,"accession":"0001415889-24-029027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-029027","line_url":"/filing/0001415889-24-029027#line-2","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831216","owner_name":"Myles David C.","owner_display_name":"Myles David C.","owner_url":"/insider/0001831216","role":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark":"O","role_mark_label":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CH. DISCOV. & NON-CLIN DEV OFF","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12452.0,"shares_display":"12,452","price_per_share":9.38,"price_display":"9.38","price_state":"stated","total_value":116799.76,"total_display":"116,799.76","total_whole":"116,800","shares_owned_after":611947.0,"shares_owned_after_display":"611,947","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-10","filed_date":"2024-12-11","scope":"insider"},{"id":8263108,"accession":"0001415889-23-015458","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-23-015458","line_url":"/filing/0001415889-23-015458#line-4","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831216","owner_name":"Myles David C.","owner_display_name":"Myles David C.","owner_url":"/insider/0001831216","role":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark":"O","role_mark_label":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CH. DISCOV. & NON-CLIN DEV OFF","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6653.0,"shares_display":"6,653","price_per_share":13.89,"price_display":"13.89","price_state":"stated","total_value":92410.17,"total_display":"92,410.17","total_whole":"92,410","shares_owned_after":574099.0,"shares_owned_after_display":"574,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-22","filed_date":"2023-11-22","scope":"insider"},{"id":8263105,"accession":"0001415889-23-015458","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-23-015458","line_url":"/filing/0001415889-23-015458","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831216","owner_name":"Myles David C.","owner_display_name":"Myles David C.","owner_url":"/insider/0001831216","role":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark":"O","role_mark_label":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CH. DISCOV. & NON-CLIN DEV OFF","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6976.0,"shares_display":"6,976","price_per_share":14.882901376146789,"price_display":"14.88","price_state":"stated","total_value":103823.12,"total_display":"103,823.12","total_whole":"103,823","shares_owned_after":580952.0,"shares_owned_after_display":"580,952","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-21","filed_date":"2023-11-22","scope":"insider","n_lines":2},{"id":8167251,"accession":"0001415889-23-015041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-015041","line_url":"/filing/0001415889-23-015041#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831216","owner_name":"Myles David C.","owner_display_name":"Myles David C.","owner_url":"/insider/0001831216","role":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark":"O","role_mark_label":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CH. DISCOV. & NON-CLIN DEV OFF","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":17.61,"price_display":"17.61","price_state":"stated","total_value":3522.0,"total_display":"3,522.00","total_whole":"3,522","shares_owned_after":561270.0,"shares_owned_after_display":"561,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-08","filed_date":"2023-11-13","scope":"insider"},{"id":7930429,"accession":"0001415889-23-014792","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-23-014792","line_url":"/filing/0001415889-23-014792#line-3","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831216","owner_name":"Myles David C.","owner_display_name":"Myles David C.","owner_url":"/insider/0001831216","role":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark":"O","role_mark_label":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CH. DISCOV. & NON-CLIN DEV OFF","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":541.0,"shares_display":"541","price_per_share":17.51,"price_display":"17.51","price_state":"stated","total_value":9472.91,"total_display":"9,472.91","total_whole":"9,473","shares_owned_after":561470.0,"shares_owned_after_display":"561,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-03","filed_date":"2023-11-03","scope":"insider"},{"id":7930426,"accession":"0001415889-23-014792","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-014792","line_url":"/filing/0001415889-23-014792#line-2","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831216","owner_name":"Myles David C.","owner_display_name":"Myles David C.","owner_url":"/insider/0001831216","role":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark":"O","role_mark_label":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CH. DISCOV. & NON-CLIN DEV OFF","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3332.0,"shares_display":"3,332","price_per_share":15.36,"price_display":"15.36","price_state":"stated","total_value":51179.52,"total_display":"51,179.52","total_whole":"51,180","shares_owned_after":562011.0,"shares_owned_after_display":"562,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-02","filed_date":"2023-11-03","scope":"insider"},{"id":7930423,"accession":"0001415889-23-014792","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-014792","line_url":"/filing/0001415889-23-014792#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831216","owner_name":"Myles David C.","owner_display_name":"Myles David C.","owner_url":"/insider/0001831216","role":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark":"O","role_mark_label":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CH. DISCOV. & NON-CLIN DEV OFF","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6668.0,"shares_display":"6,668","price_per_share":15.02,"price_display":"15.02","price_state":"stated","total_value":100153.36,"total_display":"100,153.36","total_whole":"100,153","shares_owned_after":565343.0,"shares_owned_after_display":"565,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-01","filed_date":"2023-11-03","scope":"insider"},{"id":8685251,"accession":"0001415889-23-013474","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-013474","line_url":"/filing/0001415889-23-013474#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831216","owner_name":"Myles David C.","owner_display_name":"Myles David C.","owner_url":"/insider/0001831216","role":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark":"O","role_mark_label":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CH. DISCOV. & NON-CLIN DEV OFF","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":12.67,"price_display":"12.67","price_state":"stated","total_value":253400.0,"total_display":"253,400.00","total_whole":"253,400","shares_owned_after":572011.0,"shares_owned_after_display":"572,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-19","filed_date":"2023-09-21","scope":"insider"},{"id":5023160,"accession":"0001415889-21-005860","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-005860","line_url":"/filing/0001415889-21-005860#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831216","owner_name":"Myles David C.","owner_display_name":"Myles David C.","owner_url":"/insider/0001831216","role":"Officer (CHIEF DEVELOPMENT OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF DEVELOPMENT OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF DEVELOPMENT OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":10.3,"price_display":"10.30","price_state":"stated","total_value":103000.0,"total_display":"103,000.00","total_whole":"103,000","shares_owned_after":582901.0,"shares_owned_after_display":"582,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-10","filed_date":"2021-12-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001750284","name":"Olema Pharmaceuticals, Inc.","url":"/issuer/0001750284","role":"Officer (CH. DISCOV. & NON-CLIN DEV OFF)","n_filings":8,"first_seen":"2021-12-14","last_seen":"2026-01-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001831216","retrieved_at":"2026-08-22T16:33:37+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}